SCHEMBL25063138

SCHEMBL25063138

COCCOC(=O)c1cc(NC2COC2)nc(N2CCCCC2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.36
▸ LMNA P02545 3/20 0.36
▸ TSHR P16473 4/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HPGD P15428 4/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ GAA P10253 3/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PRMT5 O14744 2/20 0.35
▸ WDR77 Q9BQA1 2/20 0.35
▸ KIF18A Q8NI77 1/20 0.35
▸ HSD17B10 Q99714 4/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALOX15 P16050 1/20 0.34
▸ MAPT P10636 4/20 0.34
▸ APAF1 O14727 3/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ SENP7 Q9BQF6 2/20 0.33
▸ SENP6 Q9GZR1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25063141 0.92 ALDH1A1 (0.42) ALDH1A1LMNAHPGDKDM4EGAA
SCHEMBL23304380 0.88 ALDH1A1 (0.43) ALDH1A1LMNATSHRNPSR1HPGD
SCHEMBL23304360 0.81 GAA (0.40) ALDH1A1TSHRHPGDKDM4EGAA
SCHEMBL23304372 0.80 ALDH1A1 (0.46) ALDH1A1LMNATSHRNPSR1HPGD
SCHEMBL23684985 0.79 RBP4 (0.41) ALDH1A1KDM4EGAAPRMT5WDR77
SCHEMBL23684560 0.78 RAD52 (0.40) ALDH1A1LMNAHPGDKDM4EGAA
SCHEMBL23684828 0.78 GBA1 (0.40) ALDH1A1KDM4EGAAKIF18ASMN1; SMN2
SCHEMBL23684496 0.78 RBP4 (0.40) ALDH1A1LMNATSHRNPSR1HPGD
SCHEMBL23304431 0.77 HTT (0.46) ALDH1A1TSHRNPSR1HPGDKDM4E
SCHEMBL23329962 0.77 HTT (0.49) ALDH1A1TSHRNPSR1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054084-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230054084-A1 COMPOUNDS AND METHODS OF USE XDH, LPXN, F12 ALDH1A1 414/4885LMNA 236/4885TSHR 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback